Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs EMTRICITABINE/TENOFOVIR DISOPROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs EMTRICITABINE/TENOFOVIR DISOPROXIL: Safety Overview

Metric EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMTRICITABINE/TENOFOVIR DISOPROXIL
Total FAERS Reports 7,225 103
Deaths Reported 141 19
Death Rate 2.0% 18.4%
Hospitalizations 535 43
Average Patient Age 46.5 yrs 34.0 yrs
% Female Patients 30.3% N/A